Stocksigma LogoStocksigma Logo

Nirma Ltd Sells 2.99% Stake in Alivus Life Sciences via Open Market

Promoter Nirma Ltd sold 36,80,000 equity shares, representing a 2.99% stake, in Alivus Life Sciences Ltd (formerly Glenmark Life Sciences Ltd) via open

Nirma Ltd Sells 2.99% Stake in Alivus Life Sciences via Open Market

Alivus Life Sciences Ltd 路 Acquisition/ Disposal of Shares 路 07 Nov 2026, 8:48 pm

Nirma Ltd Sells 2.99% Stake in Alivus Life Sciences via Open Market Promoter Nirma Ltd sold 36,80,000 equity shares, representing a 2.99% stake, in Alivus Life Sciences Ltd (formerly Glenmark Life Sciences Ltd) via open market transactions on 6th Nov'26. Following the disposal, Nirma Ltd's equity holding in Alivus Life Sciences decreased from 9,18,96,285 shares (74.73% of total voting capital; 74.54% diluted) to 8,82,16,285 shares (71.74% of total voting capital; 71.56% diluted). Total equity share capital remains at 12,29,67,281 shares, with diluted equity capital standing at 12,32,81,979 shares.

Original exchange filing (PDF)

More announcements from Alivus Life Sciences Ltd

All Alivus Life Sciences Ltd announcements